William Sharbaugh
Chief Operating Officer presso Jaguar Holding Company II
Profilo
William J. Sharbaugh è direttore operativo di PPD, Inc., direttore operativo di Pharmaceutical Product Development LLC, direttore operativo di Eagle Holding Company II LLC e direttore operativo di Jaguar Holding Company II. Fa parte del Consiglio di amministrazione di Wildcat Acquisition Holdings (UK) Ltd. Sharbaugh è stato precedentemente impiegato come direttore operativo presso Pharmaceutical Product Development LLC, vicepresidente delle operazioni di sviluppo globale presso Bristol Myers Squibb Co. e direttore di Merck & Co. È stato anche membro del consiglio di amministrazione di Clinical Research Advantage, Inc. Ha conseguito la laurea presso l'Accademia Militare degli Stati Uniti, una laurea presso la Wharton School dell'Università della Pennsylvania, una laurea presso la Temple University School of Pharmacy e una laurea presso la Boston University.
Posizioni attive di William Sharbaugh
| Società | Posizione | Inizio |
|---|---|---|
Jaguar Holding Company II
 Jaguar Holding Company II Medical SpecialtiesHealth Technology Jaguar Holding Co. II operates as a holding company. The company is headquartered in Wilmington, NC. | Chief Operating Officer | - |
Eagle Holding Company II LLC
 Eagle Holding Company II LLC Miscellaneous Commercial ServicesCommercial Services Eagle Holding Company II LLC operates as a holding company which engages in the provision of clinical development, post-approval, and laboratory services. The company is headquartered in Wilmington, NC. | Chief Operating Officer | - |
Wildcat Acquisition Holdings (UK) Ltd.
 Wildcat Acquisition Holdings (UK) Ltd. Financial ConglomeratesFinance Wildcat Acquisition Holdings (UK) Ltd. is an investment holding British company founded in 2011. The company is based in Cambridge, UK. | Director/Board Member | 05/12/2011 |
Precedenti posizioni note di William Sharbaugh
| Società | Posizione | Fine |
|---|---|---|
| PPD, INC. | Chief Operating Officer | 08/12/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2007 |
Clinical Research Advantage, Inc.
 Clinical Research Advantage, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Research Advantage, Inc. provides research services to the pharmaceutical companies and clinical research organizations. The company was founded in 1992 and is headquartered in Tempe, AZ. | Director/Board Member | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Chief Operating Officer | - |
Formazione di William Sharbaugh
| Boston University | Graduate Degree |
| US Military Academy | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Graduate Degree |
| Temple University School of Pharmacy | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Clinical Research Advantage, Inc.
Clinical Research Advantage, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Research Advantage, Inc. provides research services to the pharmaceutical companies and clinical research organizations. The company was founded in 1992 and is headquartered in Tempe, AZ. | Commercial Services |
Jaguar Holding Company II
Jaguar Holding Company II Medical SpecialtiesHealth Technology Jaguar Holding Co. II operates as a holding company. The company is headquartered in Wilmington, NC. | Health Technology |
Eagle Holding Company II LLC
Eagle Holding Company II LLC Miscellaneous Commercial ServicesCommercial Services Eagle Holding Company II LLC operates as a holding company which engages in the provision of clinical development, post-approval, and laboratory services. The company is headquartered in Wilmington, NC. | Commercial Services |
PPD, Inc.
 PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Wildcat Acquisition Holdings (UK) Ltd.
Wildcat Acquisition Holdings (UK) Ltd. Financial ConglomeratesFinance Wildcat Acquisition Holdings (UK) Ltd. is an investment holding British company founded in 2011. The company is based in Cambridge, UK. | Finance |
- Borsa valori
- Insiders
- William Sharbaugh
